Acquirer Profile
GSK Acquisitions & Deals (2026)
biopharmaceutical
Deals tracked
1
Combined value
$2.2B
Primary sector
biopharmaceutical
Active
2026
FireStrike tracks every GSK acquisition, merger, and strategic investment in real time. This page covers 1 GSK deals totaling $2.2B in disclosed deal value, spanning biopharmaceutical. Data covers 2026.
GSK Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
RAPT Therapeutics biopharmaceutical | Jan 2026 |
GSK Acquisitions — FAQ
How many acquisitions has GSK made?
GSK has made 1 acquisitions and deals tracked on FireStrike, totaling $2.2B in combined deal value.
What sectors does GSK acquire in?
GSK primarily acquires in biopharmaceutical.
What is GSK's most recent acquisition?
GSK's most recent tracked acquisition is RAPT Therapeutics for $2.2B, announced Jan 2026.
Get every GSK deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →